159 related articles for article (PubMed ID: 35087738)
1. Prognostic Significance and Gene Co-Expression Network of
Li J; Fan H; Zhou X; Xiang Y; Liu Y
Front Oncol; 2021; 11():602321. PubMed ID: 35087738
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
[TBL] [Abstract][Full Text] [Related]
3. The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation.
Zhao Y; Yu B; Liu X; Hu J; Yang Y; Namei E; Yang B; Bai Y; Qian Y; Li H
Reproduction; 2020 Dec; 160(6):853-862. PubMed ID: 33112787
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoxia on the expression of CCN2, PLAU, PLAUR, SLURP1, PLAT and ITGB1 genes in ERN1 knockdown U87 glioma cells.
Minchenko OH; Kharkova AP; Kubaichuk KI; Minchenko DO; Hlushchak NA; Kovalevska OV
Ukr Biochem J; 2014; 86(4):79-89. PubMed ID: 25509186
[TBL] [Abstract][Full Text] [Related]
5. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
[TBL] [Abstract][Full Text] [Related]
6. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
Liu M; Chen S; Zhang A; Zheng Q; Fu J
J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
[TBL] [Abstract][Full Text] [Related]
7. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
8. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
[TBL] [Abstract][Full Text] [Related]
9. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
Front Oncol; 2021; 11():611038. PubMed ID: 33937022
[TBL] [Abstract][Full Text] [Related]
10. Identifying PLAUR as a Pivotal Gene of Tumor Microenvironment and Regulating Mesenchymal Phenotype of Glioblastoma.
Fu Z; Chen Z; Ye J; Ji J; Ni W; Lin W; Lin H; Lu L; Zhu G; Xie Q; Yan F; Chen G; Liu F
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398231
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma.
Huo Z; Li X; Zhou J; Fan Y; Wang Z; Zhang Z
Cancer Cell Int; 2021 Oct; 21(1):564. PubMed ID: 34702271
[TBL] [Abstract][Full Text] [Related]
12. Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
Cetinsoy O; Anyanwu I; Krishnanand H; Natarajan G; Ramachandran N; Thomas A; Brookes KJ
J Alzheimers Dis; 2024; 99(1):241-250. PubMed ID: 38669542
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
14. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma.
Zhang Y; Yang X; Zhu XL; Wang ZZ; Bai H; Zhang JJ; Hao CY; Duan HB
Front Oncol; 2021; 11():643159. PubMed ID: 33937046
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 functions collaboratively with PLAU to promote gastric cancer progression.
Ai C; Zhang J; Lian S; Ma J; Győrffy B; Qian Z; Han Y; Feng Q
J Cancer; 2020; 11(4):788-794. PubMed ID: 31949481
[No Abstract] [Full Text] [Related]
16. Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma.
Wang Y; Sun Z; Lu S; Zhang X; Xiao C; Li T; Wu J
Front Oncol; 2022; 12():834524. PubMed ID: 36052236
[TBL] [Abstract][Full Text] [Related]
17. Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas.
Sun C; Zheng X; Sun Y; Yu J; Sheng M; Yan S; Zhu Q; Lan Q
Front Genet; 2021; 12():743738. PubMed ID: 34721530
[TBL] [Abstract][Full Text] [Related]
18. Plau/Plaur double-deficiency did not worsen lesion severity or vascular integrity after traumatic brain injury.
Kyyriäinen J; Tapiala J; Lipponen A; Ekolle Ndode-Ekane X; Pitkänen A
Neurosci Lett; 2020 Jun; 729():134935. PubMed ID: 32360936
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
